BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 38664545)

  • 1. A population-based propensity score matching analysis of risk factors and the impact on survival associated with refusal of cancer-directed surgery in patients with prostate cancer.
    Tang Y; Gao Y; Zhang R; Li T; Yang Y; Huang L; Wei Y
    Sci Rep; 2024 Apr; 14(1):9494. PubMed ID: 38664545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor characteristics, treatments, and survival outcomes in prostate cancer patients with a PSA level < 4 ng/ml: a population-based study.
    Zheng Z; Zhou Z; Yan W; Zhou Y; Chen C; Li H; Ji Z
    BMC Cancer; 2020 Apr; 20(1):340. PubMed ID: 32321456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on survival of local treatment in patients with low prostate-specific antigen, high Gleason score prostate cancer: a population-based propensity score-matched analysis.
    Liu S; Wang XY; Huang TB; Niu Q; Yao K; Song X; Zhou SY; Chen Z; Zhou GC
    Ann Palliat Med; 2020 Jul; 9(4):1708-1717. PubMed ID: 32527134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-directed surgery brings survival benefits for patients with advanced prostate cancer: a population-based propensity-score matching study.
    Chen R; Lu Y; Horie S; Vogel M; Zhang R; Zheng P; Wei Y
    J Cancer; 2023; 14(2):231-238. PubMed ID: 36741253
    [No Abstract]   [Full Text] [Related]  

  • 5. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.
    Wang C; Kishan AU; Kamrava M; Steinberg ML; King CR
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1045-1052. PubMed ID: 28721887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sociodemographic predictors of surgery refusal in patients with stage I-III colon cancer.
    Lu PW; Fields AC; Yoo J; Irani J; Goldberg JE; Bleday R; Melnitchouk N
    J Surg Oncol; 2020 Jun; 121(8):1306-1313. PubMed ID: 32227344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Survival Outcomes and Risk Factors Between Ductal Carcinoma of the Prostate and Acinar Adenocarcinoma of the Prostate: A Population-based Propensity Score-matching Study.
    Wei Y; Kobayashi T; Lu Y; Vogel M; Zhang R; Wu J; Gao Y; Lin L; Zhu Q; Ye L; Horie S; Wang X; Li T
    Eur Urol Open Sci; 2022 Dec; 46():88-95. PubMed ID: 36506256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer treatment and survivorship statistics, 2022.
    Miller KD; Nogueira L; Devasia T; Mariotto AB; Yabroff KR; Jemal A; Kramer J; Siegel RL
    CA Cancer J Clin; 2022 Sep; 72(5):409-436. PubMed ID: 35736631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated With Patient's Refusal of Recommended Cancer Surgery: Based on Surveillance, Epidemiology, and End Results.
    Hu X; Ye H; Yan W; Sun Y
    Front Public Health; 2021; 9():785602. PubMed ID: 35111717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer statistics, 2022.
    Siegel RL; Miller KD; Fuchs HE; Jemal A
    CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in Refusal of Locoregional Treatment for Prostate Adenocarcinoma.
    Dee EC; Arega MA; Yang DD; Butler SS; Mahal BA; Sanford NN; Nguyen PL; Muralidhar V
    JCO Oncol Pract; 2021 Oct; 17(10):e1489-e1501. PubMed ID: 33630666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
    Mottet N; van den Bergh RCN; Briers E; Van den Broeck T; Cumberbatch MG; De Santis M; Fanti S; Fossati N; Gandaglia G; Gillessen S; Grivas N; Grummet J; Henry AM; van der Kwast TH; Lam TB; Lardas M; Liew M; Mason MD; Moris L; Oprea-Lager DE; van der Poel HG; Rouvière O; Schoots IG; Tilki D; Wiegel T; Willemse PM; Cornford P
    Eur Urol; 2021 Feb; 79(2):243-262. PubMed ID: 33172724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between rural and urban prostate cancer patients.
    Stolzenbach LF; Deuker M; Collà-Ruvolo C; Nocera L; Tian Z; Maurer T; Tilki D; Briganti A; Saad F; Mirone V; Chun FKH; Graefen M; Karakiewicz PI
    World J Urol; 2021 Jul; 39(7):2507-2514. PubMed ID: 33155063
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.